BIOMAT Database Logo BIOMAT Database Logo

Synthesis and acrosin inhibitory activities of 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives. 2013

Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.

A series of novel 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives were designed, synthesized, and their acrosin inhibitory activities in vitro were evaluated. The results of the acrosin inhibitory activity showed that all target compounds were more potent than control TLCK. Compounds AQ-A1, AQ-D3, AQ-D4, AQ-E4 and AQ-E5 exhibited stronger acrosin inhibitory activities than control ISO-1. Especially, compound AQ-E5 displayed the most potent acrosin inhibitory activity in all the compounds, with an IC50 of 0.01μmol/mL. This study provided a new structural class for the development of novel acrosin inhibitory agents.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000176 Acrosin A trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin. Acrosomal proteinase,Akrosin,M beta-Acrosin,M beta Acrosin,beta-Acrosin, M,proteinase, Acrosomal
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
Synthesis and acrosin inhibitory activities of substituted ethyl 5-(4-aminophenyl)-1H-pyrazole-3-carboxylate derivatives.
October 2011, Bioorganic & medicinal chemistry letters,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives.
January 2005, Farmaco (Societa chimica italiana : 1989),
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
Synthesis and biological evaluation of 3-(1H-indol-3-yl)pyrazole-5-carboxylic acid derivatives.
March 2011, Archives of pharmacal research,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
5-Amino-1-phenyl-3-trifluoro-methyl-1H-pyrazole-4-carboxylic acid.
August 2009, Acta crystallographica. Section E, Structure reports online,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
5-Amino-1-phenyl-1H-pyrazole-4-carboxylic acid.
June 2008, Acta crystallographica. Section E, Structure reports online,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
1-(4-tert-Butyl-benz-yl)-3-phenyl-1H-pyrazole-5-carboxylic acid.
May 2009, Acta crystallographica. Section E, Structure reports online,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
[Synthesis of 1-phenyl-3-hydroxypyrazole-5-carboxylic acid derivatives].
September 1966, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
1-[4-(Methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole derivatives.
September 2004, Acta crystallographica. Section C, Crystal structure communications,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
Synthesis of 5-phenyl-1-(3-pyridyl)-1H-1,2,4-triazole-3-carboxylic acid derivatives of potential anti-inflammatory activity.
January 2006, Archiv der Pharmazie,
Wei Tian, and Guangqian Han, and Ju Zhu, and Jingjing Qi, and Qianqian Chen, and Juntao Zhao, and Canhui Zheng, and Ling Zhang, and Youjun Zhou, and Jiaguo Lv
Synthesis and cytotoxicity evaluation of 1-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-3-aryl-1H-pyrazole-5-carboxylic acid derivatives.
November 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!